Neurology

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results

Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use…

1 month ago

Tekton Research Selects Todata’s SiteGrades and Tod AI as Enterprise Business Intelligence Solution

OMAHA, Neb., Nov. 5, 2025 /PRNewswire/ -- Tekton Research, a leading multispecialty clinical trial site organization conducting Phase 1-4 trials,…

1 month ago

Bausch Health’s OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL,…

1 month ago

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec…

1 month ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December

PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and…

1 month ago

CEFALY Marks a Milestone: #1 Neuromodulation Device Prescribed by Veterans Health Administration Providers

DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the…

2 months ago

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

Agreements formalize research partnership combining InterCure’s global pharmaceutical platform with Cannasoul’s world-class analytics and scientific innovation Collaboration comes amidst reports…

2 months ago

Bausch Health Announces Third Quarter 2025 Results

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis…

2 months ago

Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

HAMBURG, DE / ACCESS Newswire / October 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN:…

2 months ago

Clinical Trials Market Growing at 6.51% CAGR to 2030 Driven by Hybrid and Decentralized Trial Adoption | Mordor Intelligence Forecast

HYDERABAD, India, Oct. 28, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global clinical trials market is valued at USD 90.1…

2 months ago